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SUMMARY
We describe a 40-year-old woman with severe, persistent
macroglossia following prone positioning as part of
treatment for COVID-19. We used the treatment method
of lingual compression with satisfactory results.
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BACKGROUND
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Acute macroglossia is an uncommon and perplexing
clinical problem. Previously cited aetiologies
include trauma, medication side effects, allergic
reactions, patient positioning, pressure packing of
the oropharynx and oral surgery.1–8 It has been well
described in the literature and is often self-resolving
with conservative treatment including intravenous steroids and a bite block.2 4–9 Extreme cases
may lead to dysphagia and airway compromise. In
certain cases, physicians have resorted to partial
glossectomy, a potentially morbid management
strategy, associated with postoperative speech and
swallowing difficulties.10 11 Non-operative management strategies may be a desirable alternative given
the potential for postoperative morbidity.

CASE PRESENTATION
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The patient is a 40-
year-
old African American
woman with a medical history of insulin dependent
diabetes mellitus, pancreatic insufficiency, asthma,
hypertension and ulcerative colitis. She presented
to the emergency department with 1 week of fevers,
shortness of breath and diarrhoea. The patient was
found to be positive for COVID-19. Her respiratory function quickly worsened despite breathing
treatments. She was intubated and admitted to the
intensive care unit.
The patient was treated with a combination of
hydroxychloroquine, methylprednisolone and
tocilizumab. Despite medical management, she
developed persistent, severe hypoxia and an acute
respiratory distress syndrome-
like picture with a
partial pressure of oxygen to fraction of inspired
oxygen (PaO2:FiO2) ratio <100. In order to
improve oxygenation, prone positioning was used
for a total of 11 days. Our institutional prone positioning protocol includes 16 hours of prone positioning, followed by 8 hours of supine positioning.
Worsening lower facial oedema and macroglossia
was noted as a result of patient positioning; however,
the benefits of improved oxygenation were thought
to outweigh any risks. At the conclusion of prone
positioning, the patient’s macroglossia was severe,
with the tongue nearly capable of resting on her

chest. Thyroid stimulating hormone (TSH) was
sent and noted to demonstrate a relatively hyperthyroid state at 0.10 uIU/mL. A free T4 was then
checked reflexively and was normal at 1.22 ng/dL.
Growth hormone was not checked. We attributed
the patient’s macroglossia solely to prolonged
prone positioning.
Otolaryngology was consulted. An additional
10-day course of methylprednisolone in addition
to a bite block was recommended. However, this
yielded only mild improvement. The patient’s tongue
remained significantly edematous, protruding from
the mouth with pressure injuries developing over
the ventral surface where the tongue was in contact
with teeth and the endotracheal tube. Tracheostomy
was performed on hospital day 26 after approval
to perform the procedure in the setting of active
COVID-19 infection was obtained from intensive
care unit leadership.
The patient’s macroglossia persisted despite our
interventions. In an effort to avoid partial glossectomy, lingual compression was applied on hospital
day 27. The wrap consisted of saline moistened
gauze loosely wrapped around the tongue, followed
by a compressive Coban wrap (3M, St. Paul, Minnesota, USA) applied distal to proximal (figure 1).
Care was taken to not create a lingual tourniquet.
Initially, the wrap was applied once daily and left
in place for 12 hours at a time. Marked improvement was observed after the first wrapping and we
continued to note improvement after subsequent
treatments. However, lingual oedema was noted to
worsen during the 12 hours periods following treatment. On treatment day 8, lingual compression was
applied twice daily for a period of 8 hours, followed
by 4 hours without lingual compression.

OUTCOME AND FOLLOW-UP

On treatment day 11, the patient was able to retract
the tongue into her mouth without difficulty and
lingual compression was discontinued (figure 2).
There was no evidence of persistent injury to the
tongue as a result of treatment. The patient was
discharged to a long-term assisted care facility on
hospital day 52.

DISCUSSION

Acute-
onset macroglossia can present significant
challenges and distress to the patient when unresponsive to traditional conservative measures. The
most commonly cited treatment methods include
intravenous steroids and bite blocks. A tracheostomy
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Figure 1

Anterior and lateral view of lingual compressive wrap.

may be necessary to minimise external compression and preserve
airway patency. It has been noted that endotracheal tubes and
throat packing can result in lingual oedema due to disruption of
venous drainage.2 4 5
Several previously published case reports discuss a variety of
techniques for non-operative management of refractory macroglossia. Saah et al6 describe a technique in which they manually
reduced the tongue into the oral cavity combined with a gauze
head wrap to approximate the jaw and contain the tongue. In
that report, the authors describe resolution of oedema within
48 hours after treatment. They hypothesise that reduction of
the tongue alone relieves lymphovascular obstruction resulting
in resolution of macroglossia. Shanti et al12 describe a slightly
different technique involving manual lingual reduction followed
by maxillary mandibular fixation. In this instance, fixation was
maintained for 3 weeks with resolution of macroglossia at the
conclusion of treatment.
In some cases, the extent of lingual oedema will not permit
manual reduction. Foreman et al9 used bite blocks placed under
anaesthesia. The persistent oedema in this case was believed
to be secondary to extrinsic compression of the tongue by the
teeth. The patient tolerated the bite blocks well and had resolution of the swelling within a few days. Additionally, Johnson et
al13 used a wrapping compression technique for a patient with
persistent angioedema from C1 esterase inhibitor deficiency. The
author noted improvement following 4 days of compression for
12 hours each day.
Our patient’s macroglossia was the result of a prolonged
course of prone positioning for treatment of COVID-19. This

Figure 2 Progressive resolution of macroglossia with lingual
compression. (A) Treatment day 1 prior to initiation of lingual
compressive therapy; (B) treatment day 3; (C) treatment day 4; (D)
treatment day 10; (E) treatment day 13 and (F) treatment day 14.
2

mechanism has previously been described in the literature
following lengthy surgical cases.2 4 5 7 Her condition persisted
despite first-line treatment steroids and bite blocks. Her macroglossia was too severe for manual reduction into the oral cavity.
Application of a lingual compression was effective in resolving
macroglossia while avoiding the need for partial glossectomy. We
found that increasing time of compression from 12 hours daily,
as described by Johnson et al,13 to a total compression time of
16 hours daily did not adversely affect the patient and may have
shortened overall treatment duration.

Learning points
►► Acute macroglossia is a rare clinical problem that can be

distressing to both patients and providers.

►► Acute macroglossia is typically managed conservatively with

steroids and bite blocks. If macroglossia is refractory or if
partial glossectomy is being considered, lingual compression
may be safely used with satisfactory results.
►► A scheduled protocol with 8 hours of compression followed
by 4 hours without compression is safe and effective.
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